Semi-quantitative cerebral blood flow parameters derived from non-invasive [<sup>15</sup>O]H<sub>2</sub>O PET studies by Koopman, Thomas et al.
  
 University of Groningen
Semi-quantitative cerebral blood flow parameters derived from non-invasive [15O]H2O PET
studies
Koopman, Thomas; Yaqub, Maqsood; Heijtel, Dennis F. R.; Nederveen, Aart J.; van Berckel,
Bart N. M.; Lammertsma, Adriaan A.; Boellaard, Ronald
Published in:
Journal of Cerebral Blood Flow and Metabolism
DOI:
10.1177/0271678X17730654
IMPORTANT NOTE: You are advised to consult the publisher's version (publisher's PDF) if you wish to cite from
it. Please check the document version below.
Document Version
Publisher's PDF, also known as Version of record
Publication date:
2019
Link to publication in University of Groningen/UMCG research database
Citation for published version (APA):
Koopman, T., Yaqub, M., Heijtel, D. F. R., Nederveen, A. J., van Berckel, B. N. M., Lammertsma, A. A., &
Boellaard, R. (2019). Semi-quantitative cerebral blood flow parameters derived from non-invasive
[15O]H2O PET studies. Journal of Cerebral Blood Flow and Metabolism, 39(1), 163-172.
https://doi.org/10.1177/0271678X17730654
Copyright
Other than for strictly personal use, it is not permitted to download or to forward/distribute the text or part of it without the consent of the
author(s) and/or copyright holder(s), unless the work is under an open content license (like Creative Commons).
Take-down policy
If you believe that this document breaches copyright please contact us providing details, and we will remove access to the work immediately
and investigate your claim.
Downloaded from the University of Groningen/UMCG research database (Pure): http://www.rug.nl/research/portal. For technical reasons the
number of authors shown on this cover page is limited to 10 maximum.
Download date: 13-11-2019
Original Article
Semi-quantitative cerebral blood flow
parameters derived from non-invasive
[15O]H2O PET studies
Thomas Koopman1, Maqsood Yaqub1, Dennis FR Heijtel1,2,
Aart J Nederveen3, Bart NM van Berckel1,
Adriaan A Lammertsma1 and Ronald Boellaard1,4
Abstract
Quantification of regional cerebral blood flow (CBF) using [15O]H2O positron emission tomography (PET) requires the
use of an arterial input function. Arterial sampling, however, is not always possible, for example in ill-conditioned or
paediatric patients. Therefore, it is of interest to explore the use of non-invasive methods for the quantification of CBF.
For validation of non-invasive methods, test–retest normal and hypercapnia data from 15 healthy volunteers were used.
For each subject, the data consisted of up to five dynamic [15O]H2O brain PET studies of 10min and including arterial
sampling. A measure of CBF was estimated using several non-invasive methods earlier reported in literature. In addition,
various parameters were derived from the time-activity curve (TAC). Performance of these methods was assessed by
comparison with full kinetic analysis using correlation and agreement analysis. The analysis was repeated with normal-
ization to the whole brain grey matter value, providing relative CBF distributions. A reliable, absolute quantitative
estimate of CBF could not be obtained with the reported non-invasive methods. Relative (normalized) CBF was best
estimated using the double integration method.
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Introduction
Regional cerebral blood ﬂow (CBF) represents the
amount of blood that perfuses a volume of tissue, i.e.
mL blood per mL of tissue per min. To date, the
accepted unit for CBF is mLcm3min1, where
mLcm3 is used to indicate the transfer from blood
to tissue.1 Several modalities can be used to measure
perfusion,2 but positron emission tomography (PET)
with oxygen-15 labelled water is considered to be the
reference standard method.
Over the years, various methods have been developed
for deriving CBF from a dynamic [15O]H2O PET
scan.3–14 Ultimately, all these methods are based on
Kety’s compartment model for (inert) H2O.
15 Solving
the diﬀerential equation leads to a convolution of the
tissue response with the arterial input function (AIF).
Quantitative studies therefore require the measurement
of the AIF, which is obtained most reliably through
continuous arterial sampling.16 However, this is a
somewhat invasive procedure, which is less suitable
for routine clinical studies. In some cases, arterial sam-
pling is clinically not feasible, for example in ill-condi-
tioned patients or in children with Moyamoya disease.
In case arterial sampling is not possible, it may be of
interest to apply non-invasive methods that can estimate
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CBF or relative CBF distributions across the brain to
identify regions with reduced perfusion. However,
before using non-invasive methods, it is important to
investigate their accuracy and precision against full-
quantitative kinetic approaches.
One non-invasive approach is the use of an image-
derived input function (IDIF).17 The main challenge for
this approach is the limited spatial resolution inherent
to PET. This aﬀects the quality of the measured input
function due to partial volume eﬀects. This particularly
aﬀects CBF studies because, in contrast to myocardial
blood ﬂow studies, there are no large vascular struc-
tures within the ﬁeld of view.17 The IDIF approach
seems very promising, but requires complex and accur-
ate methodology for partial volume correction and
delineation of the arteries. As a consequence, use of
IDIF for CBF measurements is not widely used and
had limited success so far.
Instead, this study focuses on validation of simpliﬁed
methods independent of a measured AIF. As far as we
know, the methods described below are all that have
been reported for [15O]H2O PET.
10,11,13 We also
included the integral count approach from early brain
activation studies.18 In MR perfusion research, often
additional parameters describing the time intensity
curve are reported, such as the time-to-peak (TTP),
wash-in slope and the peak height. Their equivalents
for PET have not been evaluated, because typically in
dynamic PET studies, frame times are not shorter than
5 s and data are noisy making it diﬃcult to estimate
these parameters reliably. These parameters were
included to conﬁrm to this hypothesis.
The aim of this study was to select the best method
based on their performance to estimate (relative) CBF,
initiated by our interest in studying CBF changes in
children suﬀering from Moyamoya disease for whom
arterial sampling is clinically not feasible. In a head-to-
head comparison with the reference kinetic method and
including a report on the test–retest variability, this
paper should provide clarity on the best non-invasive
method for obtaining (relative) CBF.
Material and methods
Subjects and study protocol
PET scans were acquired on a Gemini TF-64 PET/CT
system (Philips Healthcare, Cleveland, TN, USA). The
research participants were 16 healthy volunteers. All
participants gave written informed consent for this
study prior to inclusion. The study has been approved
by the medical ethical review committees of both parti-
cipating centers; the Amsterdam Medical Center and
the VU University Medical Center. The study was con-
ducted in accordance with the Declaration of Helsinki.
Characteristics of the participants and scanning proto-
col have been described previously.19 In brief, each
person underwent ﬁve [15O]H2O scans in two separate
scanning sessions. During the ﬁrst scan session, people
were scanned twice under baseline cerebrovascular con-
ditions and once during hypercapnia. During the
second session, planned 28 days later, a single baseline
scan was followed by a hypercapnia scan. Hypercapnia
was induced using 5% CO2 enriched air.
Each person received an arterial line for blood
sampling and a venous line in the opposite arm for
administration of [15O]H2O. Scanning sessions started
with a 1min low-dose CT scan, which served for
attenuation and scatter correction of the subsequent
PET acquisitions. Emission scans were acquired in list
mode for 10min. A bolus of 800MBq [15O]H2O was
administered at the start of each scan. Arterial blood
was measured continuously using an automatic blood
sampler.16 The resulting AIF was calibrated using three
manual arterial samples collected at 5.5, 8 and 10min
post injection.
The scans were acquired in list mode and recon-
structed into 26 frames of 1 10 s, 8 5 s, 4 10 s,
2 15 s, 3 20 s, 2 30 s, 6 60 s. The row action max-
imum likelihood algorithm (RAMLA) as provided by
the scanner manufacturer was used for reconstruction
of the scans with an isotropic voxel size of 2mm.
Thereafter, the dynamic images were smoothed using
an isotropic 5mm FWHM Gaussian kernel.
Brain region time-activity curves
T1-weighted MR images were acquired on a Philips 3T
Intera System (Philips Healthcare, Best, the
Netherlands) at the Amsterdam Medical Center. This
anatomical reference scan of each subject was co-
registered to the emission scans using the SPM12 soft-
ware package (Functional Imaging Laboratory, 2014,
London, UK). For this purpose, emission scans were
summed over all time frames. After co-registration, the
anatomical scans were segmented using PVELab
(Neurobiology Research Unit, 2010, Copenhagen,
Denmark) into grey matter (GM), white matter (WM)
and cerebrospinal ﬂuid (CSF) and divided into 67 brain
regions using the Hammers brain atlas.20,21
Segmentations were then applied to the dynamic
[15O]H2O images to generate regional GM time-activity
curves (TACs). Furthermore, the union of GM and
WM was used as whole brain mask for some methods;
this will further be referred to as whole brain.
CBF reference methods
CBF was calculated using two reference methods: (a)
full kinetic analysis of brain region TACs using
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non-linear regression (NLR) and (b) the basis function
method (BFM)14 for voxel wise (¼parametric) calcula-
tions. Thus, NLR gives the CBF per region, and BFM
gives a parametric map of CBF. Both methods used the
single tissue compartment model with additional arter-
ial blood volume parameter:
Ct tð Þ ¼ Va  Ca tð Þ þ 1 Vað Þ  f  e  f tV1Tð Þ  Ca tð Þ
ð1Þ
Here CtðtÞ is the tissue concentration of the tracer
over time, Va the arterial blood volume fraction, CaðtÞ
the AIF, f the cerebral blood ﬂow (f¼CBF) and VT the
volume of distribution. For NLR, the AIF is estimated
by the measured arterial tracer concentration corrected
for delay. Dispersion correction was omitted in favour
of ﬁtting the arterial blood volume parameter. Blood
ﬂow estimated with this parameter is near equivalent to
blood ﬂow estimated with dispersion correction, as
noted by Bol et al.22 For BFM, the measured arterial
tracer concentration is corrected for both delay and
dispersion as described previously.14
Simplified methods
Implementation of the methods described in this paper
used the following calculations as published in the ori-
ginal papers. All methods are based on Kety’s diﬀeren-
tial equation for the one-tissue reversible compartment
model, see equation (2), where CtðtÞ is the tissue con-
centration of the tracer over time, CaðtÞ is the arterial




¼ fCa tð Þ  f
VT
CtðtÞ ð2Þ
Mejia et al.10 introduced the double integration
method (DIM),10 which eliminates the need for the
AIF by using the whole brain as a reference and assum-
ing the global CBF to be the normal average value.
The method is based on the double integration of
equation (2), leading to equation (3), where end time
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ð3Þ
The double integration of the arterial tracer concen-
tration is substituted by A, which is estimated using the
TAC of the whole brain Ct1ðtÞ and an assumed global


















A is calculated with f1 ¼ 0:5mLcm3min1 and
VT1 ¼ 0:86. With A substituted in equation (3), the
ﬂow is calculated for every voxel, ﬁxing VT at 0.86.
Note that in the original publication, VT1 and VT
were ﬁxed at unity; however, a later (1992) recom-
mended value is used here.23
In 1996, the DIM was extended by Watabe et al.11
using a two-step calculation strategy to estimate the
global CBF and volume of distribution instead of
ﬁxing them to the normal average value. In Watabe’s
method, the same substitution is performed, and the
TAC of a second reference region Ct2ðtÞ is introduced,
yielding equation (5). This second region was deﬁned as




























Fixing VT2 at 0.86, NLR is performed using a trust-
region reﬂective algorithm to ﬁt the values for f1, VT1
and f2. A is then calculated using the ﬁtted values for f1
and VT1 and substituted in equation (3) to calculate f
for every voxel, again ﬁxing VT at 0.86.
Another approach was published by Treyer et al.. It
is based on Alpert’s weighted integration method24 to
estimate both CBF and the washout parameter k2, but
uses a standard AIF.13 This standard input function is
corrected for delay and dispersion (Meyer’s method8).
Because CBF depends on the amplitude of the AIF,
and k2 does not, estimated CBF values were then
scaled using the estimated k2 by making their averages
in GM equal. However, as Treyer at al. note in their
discussion, this causes a bias because the washout par-
ameter is deﬁned as k2 ¼ fVT. Therefore, in this study,
the estimated CBF values were scaled by making the
estimate GM value equal to the average k2 times VT,
ﬁxing VT at 0.86. Unlike in the original study, we did
not use a separate set of measured input functions to
create a standard input function. Instead, the measured
input functions of the subjects were used. However, to
ensure that the used input function was independent of
the subject, a ‘standard’ input function was produced
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per subject by averaging the input functions of all other
subjects. Before averaging, the functions were normal-
ized by their integral and the time of the peaks was
aligned, as was done in the original study.13
For the above methods, the ﬁrst 3min of scan data
were used; the following TAC-derived parameters used
all or part of the 10-min scans. The deﬁnitions of the
TAC-derived parameters are illustrated in the supple-
mentary material. These CBF-related parameters were
derived from the TAC: the area under the time activ-
ity curve (AUC); the AUC for a 60-s interval (AUC60)
after the beginning of the wash-in (t0); peak height
(peak); time between the beginning of the wash-in
and the peak (TTP); the maximum wash-in slope
(slope); the wash-out curve ﬁtted with an exponential
function (washoutEXP) and a power function (wash-
outpowerlaw). The parameters were calculated using
Matlab 7.10 (R2010a) (The MathWorks, Inc.,
Natick, MA, USA).
Evaluation of simplified methods
The various parameters associated with CBF were com-
pared with the reference method using both correlation
and agreement analysis. Firstly, using the simpliﬁed
CBF estimates per brain region and NLR as reference,
Pearson correlation coeﬃcients were calculated. The
ﬁve highest correlating simpliﬁed parameters were
included for further investigation.
Secondly, Bland–Altman analysis25 was used to
investigate agreement. The results are reported as the
mean diﬀerence (an estimate of the bias) and 1.96 times
the standard deviation of the diﬀerences (an estimate of
the precision). The results do not focus on individual
regions, but rather report the average agreement for
brain regions. To include the parameters with diﬀerent
units, the CBF estimates of each method were con-
verted to a percentage of the sample average—the aver-
age over all subjects—and the standard deviation of the
diﬀerences were reported in percentage points. Note
that the mean diﬀerence is now zero and hence not
reported. In addition, brain region values of all meth-
ods were normalized to their whole brain value provid-
ing relative CBF, and the agreement of the parameters
relative to whole brain was also investigated. Using
BFM as the reference, the agreement analyses were
repeated using the parametric maps.
Repeatability of all methods was investigated using
the brain region values of the repeated baseline meas-
urements. The repeatability performance is reported by
the repeatability index (RI), the repeatability coeﬃ-
cient25 as percentage of the sample average,19 again
allowing to compare the repeatability of metrics with
diﬀerent units. The repeatability was re-calculated after
normalizing each scan to the whole brain value.
Intra-session test–retest performance was investigated
using the two consecutive baseline scans of the ﬁrst
scanning session. For inter-session repeatability, the
baseline scan of the second session was used in combin-
ation with the ﬁrst baseline scan of the ﬁrst session. The
95% conﬁdence interval of the repeatability indices is
also reported.
Finally, agreement analysis was performed on hyper-
capnia-induced diﬀerences estimated by each method.
The relative changes between the baseline and hyper-
capnia scans, see equation (6), were calculated with
each method for all brain regions. For this, diﬀerences
between scan 3 and scan 1 and between scan 5 and scan
4 were used. These diﬀerences were compared to the
diﬀerences found by the reference method (NLR) and






Simulations were performed in order to better under-
stand the behaviour of the CBF methods. TACs were
generated without noise to investigate bias as function
of simulated CBF. The TACs were generated with the
single tissue compartment model, as described in equa-
tion (1), and a representative input function. The rep-
resentative input function was constructed from all
measured input functions after normalization by their
integral and aligning the peaks temporally. The volume
of distribution VT and the arterial blood volume frac-
tion Va were kept constant and simulated CBF param-
eter f ranged from 0.2 to 1.0 in 128 steps. In addition,
noise was added to the TACs to investigate the noise
characteristics of the methods. The noise level ranged
from 0% to 16% coeﬃcient of variation (COV) and
was increased in 128 steps. Details of the noise simula-
tion have been described earlier.26 For every combin-
ation of noise and CBF, 500 noisy TACs were
generated.
The simulated data were then analysed with the
BFM and simpliﬁed methods to estimate CBF. The
whole brain reference TAC for the DIM was a noise
free TAC generated with f ¼ 0:5mLcm3min1.
Watabe’s extension of the DIM was not investigated.
The scale factor for Treyer’s method was calculated
with the average k2 and K1 of all generated TACs.
The mean observed CBF errors and their standard
deviations are reported in error maps. The errors as
percentage of simulated CBF are reported as relative
error maps. Error plots are shown for the noise free
TACs and the TACs with 8% noise level.
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Results
Average time between sessions was 34 days (25–45
days). From the total of 80 scans, 70 scans were suc-
cessfully evaluated. Acquisition failed for 10 scans of 5
volunteers: tracer production failure twice, inadequate
arterial blood sampling twice, and acute nausea once.
Details were reported elsewhere.19
The Pearson correlation coeﬃcients per scan
between regional CBF values of simpliﬁed metrics
and the reference method (NLR) are presented in
Figure 1. Results obtained with BFM were added for
comparison. Highest correlations were found for DIM,
Watabe, Treyer, AUC60, and the peak height. The
other measures (washoutEXP, washoutpowerlaw, AUC,
slope and TTP) showed lower correlation and were
excluded from further analysis.
The results of the agreement analysis using brain
regions are summarized in Table 1. The mean diﬀerence
was zero for the DIM and Watabe’s method. Treyer’s
method showed a mean diﬀerence that was signiﬁcantly
diﬀerent from zero (a<.001), indicating bias. The
standard deviations of the diﬀerences are an estimation
of precision and show that for the absolute estimation
of CBF, the DIM and Treyer’s method are most pre-
cise, followed by the AUC60 and peak height. For esti-
mation of relative CBF, the DIM and the AUC60 are
Figure 1. Correlation per scan of the investigated methods with full kinetic analysis using NLR.
NLR: non-linear regression.
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most precise, followed by the Treyer’s method and peak
height. Watabe’s method was most imprecise for esti-
mation of both absolute and relative CBF. Table 2
shows the same results, but for parametric comparison.
The standard deviations of the diﬀerences are larger
than for regional comparison. The DIM seems least
aﬀected by this.
Figure 2 shows voxel-wise scatter and Bland–
Altman plots of relative CBF calculated with the
DIM, Treyer’s and AUC60 methods using BFM as ref-
erence. Mean diﬀerences were zero due to normaliza-
tion to the whole brain average. An example of
parametric maps calculated with the various methods
can be found in the supplementary material.
Repeatability performance is shown in Table 3 for
intrasession (n¼ 14 subjects) and Table 4 for interses-
sion (n¼ 14 subjects). The DIM shows the same results,
both with and without normalisation to the whole
brain. Results of Watabe’s method show the largest
RI for intrasession repeatability. The TAC-derived
parameters (AUC60 and peak height) show the best
reproducibility indices for relative CBF estimation.
The intersession RIs are approximately twice as large
as the intrasessions RIs for Treyer’s method, AUC60
and peak height.
Agreement on hypercapnia induced diﬀerences is
presented in Table 5. Scatter and Bland–Altman plots
of these diﬀerences are shown in the supplementary
material. The DIM and Watabe’s method show a
clear disagreement with the reference method for esti-
mating diﬀerences between the hypercapnia scans and
the baseline scans. Treyer’s method shows best
performance among the simpliﬁed methods.
The error maps and plots showing the simulation
results are available in the supplementary material.
BFM shows the least bias, only slightly overestimating
CBF for simulated CBFs >0.8mLcm3min1.
The sawtooth pattern visible on the BFM error graph
for the simulation without noise is caused by the use of
the limited number of basis functions. The DIM shows
slight overestimation at low CBF and slight underesti-
mation at high CBF. The AUC60 and Peak methods
largely underestimate and overestimate CBF at low
and high simulated CBF values. The bias of the peak
method also shows dependence on noise, which is vis-
ible in the error maps, whereas the bias of all other
methods is independent on noise. Treyer’s method
shows overestimation of CBF over the entire simulated
CBF range, but increases with simulated higher CBF
values
Table 1. Regional agreement with NLR.
Relative CBF
Method Mean (95% CI) 1.96 SD 1.96 SD (% of sample average) 1.96 SD (% of global CBF)
BFM 0.00 (0.01 – 0.01) 0.08 (0.06–0.10) 16.6 (13.1–20.1) 5.3 (5.1–5.4)
DIM 0.01 (0.01 – 0.03) 0.18 (0.14–0.21) 36.6 (28.9–44.4) 10.4 (10.2–10.7)
Watabe 0.00 (0.03 – 0.03) 0.27 (0.22–0.33) 56.7 (44.7–68.6) 15.4 (15.0–15.8)
Treyer 0.12 (0.09–0.14) 0.21 (0.17–0.25) 37.5 (29.6–45.4) 13.0 (12.7–13.3)
AUC60 N/A N/A 44.0 (34.7–53.3) 10.2 (10.0–10.5)
peak N/A N/A 45.2 (35.7–54.7) 13.2 (12.8–13.5)
Note: Average over all brain regions and 95% confidence interval between brackets (95% CI). The third column is converted to percentages by dividing
over the average of all subjects, relative CBF is a percentage of the global CBF per scan.
BFM: basis function method; CBF: cerebral blood flow; DIM: double integration method; SD: standard deviation.
Table 2. Parametric agreement with BFM. Average over all brain regions and 95% confidence interval between brackets (95% CI).
Relative CBF
Method Mean 1.96 SD 1.96 SD (% of sample average) 1.96 SD (% of global CBF)
DIM 0.01 (0.02–0.04) 0.23 (0.19–0.27) 45.4 (37.7–53.1) 27.0 (22.4–31.6)
Watabe 0.03 (0.03–0.10) 0.52 (0.43–0.61) 96.7 (80.3–113.1) 29.0 (24.1–33.9)
Treyer 0.10 (0.06–0.13) 0.29 (0.24–0.34) 50.7 (42.1–59.3) 34.7 (28.8–40.6)
AUC60 N/A N/A 52.0 (43.2–60.8) 28.1 (23.3–32.9)
Peak N/A N/A 55.0 (45.6–64.3) 35.4 (29.4–41.4)
BFM: basis function method; CBF: cerebral blood flow; DIM: double integration method; SD: standard deviation; N/A: not applicable.
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Figure 2. Voxel wise scatter and Bland–Altman plots of the methods vs. BFM after normalization to whole brain (relative CBF).
BFM: basis function method; CBF: cerebral blood flow.
Table 3. Intrasession test–retest repeatability from data of 14
subjects.
Relative CBF
Method RI (%) RI (%)
NLR 27.3 (25.7–28.9) 14.4 (13.6–15.3)
BFM 26.1 (24.6–27.6) 15.2 (14.3–16.0)
DIM 12.8 (12.1–13.5) 12.8 (12.1–13.5)
Watabe 37.2 (35.1–39.3) 14.4 (13.6–15.2)
Treyer 21.5 (20.2–22.7) 15.6 (14.7–16.5)
AUC60 23.5 (22.2–24.8) 10.3 (9.7–10.8)
Peak 23.2 (21.9–24.5) 12.3 (11.6–13.0)
Note: Average over all brain regions and 95% confidence interval
between brackets (95% CI).
BFM: basis function method; CBF: cerebral blood flow; DIM: double inte-
gration method; SD: standard deviation; RI: repeatability index.
Table 4. Intersession test–retest repeatability from data of 14
subjects.
Relative CBF
Method RI (%) RI (%)
NLR 29.5 (27.8–31.3) 14.4 (13.5–15.2)
BFM 31.8 (30.0–33.6) 15.0 (14.1–15.8)
DIM 14.3 (13.5–15.2) 14.3 (13.5–15.2)
Watabe 36.9 (34.8–39.0) 17.2 (16.2–18.2)
Treyer 43.9 (41.4–46.4) 16.6 (15.7–17.5)
AUC60 49.8 (46.9–52.6) 11.7 (11.0–12.3)
peak 47.5 (44.8–50.1) 12.9 (12.2–13.7)
Average over all brain regions and 95% confidence interval between
brackets (95% CI).
BFM: basis function method; CBF: cerebral blood flow; DIM: double inte-
gration method; SD: standard deviation; RI: repeatability index.
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The error precision maps show that precision of the
AUC60 method is constant at diﬀerent CBF and all
other methods show declining precision with increasing
CBF. All methods show worse precision with increasing
noise levels. For BFM and the DIM, the precision is
proportional to CBF, which can be seen in the relative
precision maps.
Discussion
This study compared a wide range of simpliﬁed meth-
ods for estimating (absolute and relative) cerebral per-
fusion, independent of measurement of the AIF, in
healthy volunteers. Their performance was investigated
against reference kinetic methods, which use an AIF.
Moreover, our study included assessment of repeatabil-
ity performance of all metrics and methods tested; both
intra- and inter-session.
Most TAC-derived parameters (washoutEXP, wash-
outpowerlaw, AUC, slope and TTP) showed poor correl-
ation with NLR-derived CBF. As expected, these
parameters are thus of little value for estimating CBF.
Two TAC-derived parameters, the peak height and the
AUC60, do show high correlation (see Figure 1). The
AUC60 showed better results than the peak height:
higher correlation, lower RIs and smaller standard
deviation of the diﬀerences. Peak height does show a
linear relationship, yet its performance is worse.
Relative CBF distributions can be estimated with
reasonable precision using the DIM and AUC60 meth-
ods. However, it is known that the relationship between
integral counts and CBF is nonlinear. This can also be
seen in Figure 2 and this causes the lower contrast
which can be seen in the parametric maps (supplemen-
tary material). This is probably also why the AUC60
has a lower RI for both inter- and intra-session repeat-
ability. Because the DIM does not show worse agree-
ment performance, it should be the method of choice
for estimating relative CBF. However, because the
global CBF is always assumed to be the normal aver-
age, this method cannot estimate absolute CBF
and should only be considered when studying relative
CBF changes between subjects or longitudinally. This
is exempliﬁed by the disagreement of this method
for absolute longitudinal changes, as presented in
Table 5.
In our study, we observed that none of the non-
invasive methods are able to estimate absolute CBF
reliably. Watabe’s method estimates global CBF using
NLR. However, as they clearly explain in the original
paper, there exists a very shallow error surface around
the optimal solution. Hence, the method is very sensi-
tive to get trapped in local minima, and Treyer et al.
indeed report this as well. Furthermore, Watabe et al.11
mention in their discussion that ‘‘From the simulation
it follows that a 2-min administration period performs
better than a 1-min period.’’ Perhaps this explains the
disparity in the results. In this study (and in the study of
Treyer et al. too), a bolus injection was used, which had
an even shorter administration period of 15 s (20 s in the
study of Treyer et al.). Clearly, the method performs
worse on bolus injection data and cannot be recom-
mended for estimation of CBF for our imaging
procedure.
In comparison with Watabe’s method, Treyer’s
method shows better precision for estimating absolute
CBF. However, Treyer’s method showed overesti-
mations of CBF in this dataset. The reason for this is
unclear, but could have to do with the presumed
volume of distribution. If we look at the precision in
percentage points, it is clear that the precision of
Treyer’s method is similar to the DIM’s precision,
whereas the TAC-derived parameters have a worse pre-
cision. For the assessment of CBF and relative CBF
changes, most simpliﬁed methods show similar RIs
the reference methods (NLR or BFM with arterial sam-
pling) for intra-session CBF and relative CBF data and
somewhat worse RIs for inter-session CBF values.
When short-term longitudinal changes in CBF need
to be assessed, Treyer’s method may be considered.
The simulations largely conﬁrmed the observations
seen in the clinical data. Generally, the BFM provided
most accurate and robust CBF estimates, while several
simpliﬁed non-invasive methods suﬀer from substantial
bias and poor precision. In line with the clinical studies,
the DIM seems to be able to estimate CBF accurately
and with high precision over a large range of simulated
CBF values and noise levels and comparable to those
seen with BFM. It should be noted that we did not
simulate deviations in volume of distribution or input
functions and some observations for the simpliﬁed
methods may therefore be more optimistic than seen
in the clinical data. Yet, in general, the simulations
show the same trends as seen in the clinical studies.
Table 5. Regional agreement with NLR of hypercapnia induced
differences.
Method Mean 1.96 SD
BFM 2.4 (1.6 – 6.3) 32.7 (25.8–39.6)
DIM 24.5 (29.5 – 19.5) 41.1 (32.5–49.8)
Watabe 31.9 (37.7 – 26.2) 47.2 (37.3–57.2)
Treyer 1.6 (3.0 – 6.3) 38.0 (30.0–46.1)
AUC60 3.7 (11.0 – 3.6) 59.9 (47.2–72.5)
Peak 4.1 (11.5 – 3.3) 60.9 (48.0–73.7)
Average over all brain regions and 95% confidence interval between
brackets (95% CI).
BFM: basis function method; CBF: cerebral blood flow; DIM: double inte-
gration method; SD: standard deviation; NLR: non-linear regression.
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Conclusion
In this study, we evaluated the performance of a wide
range of non-invasive methods for quantifying CBF
and/or relative CBF which can be applied in studies
where the collection of an AIF is clinically not feasible
(e.g. in children with Moyamoya disease). Performance
of these methods was compared with quantitative CBF
derived using a kinetic model including an AIF. The
double integration method showed the best perform-
ance for measuring relative cerebral perfusion (and its
change) without arterial sampling. The main disadvan-
tage of this method is the inability to estimate global
CBF. Therefore, it is concluded that among the non-
invasive methods tested, the double integration method
seems to be most optimal method for measuring rela-
tive CBF. None of the non-invasive methods were able
to measure absolute CBF accurately, but Treyer’s
method may be considered when studying changes in
CBF within the same subject in a longitudinal setting.
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